AMA AMOFA: Open Payments
NPI 1861167082 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 12 payments from 9 companies in 2025. Trend: 2023 $1,782 · 2024 $1,934 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| Alkermes, Inc. | 1 | $25 |
| Braeburn Inc. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Corium, LLC | 1 | $11 |
Products named: REXULTI, AUSTEDO XR, MAVYRET, VIVITROL, BRIXADI, INVEGA SUSTENNA, Azstarys.
Industry payments across IN — which companies pay providers there.
